miR4306 inhibits the proliferation, migration and invasion of osteosarcoma cells by down-regulating the expression of special AT-rich sequence-binding protein 2
LI Shulin1,2, LIAO Yilin3, ZHOU Zijie4, XIAO Zhengwei1, SU Lingbo1, LI Junjie1,
LAN Qing1, CHEN Mingdi1, GUO Huiling1,2, YAN Laipeng1,2, TANG Faqiang1,2
(1. Provincial Clinical Medical College, Fujian Medical University, Fuzhou Fujian 350001; 2. The First Department of Orthopedics, Fujian Provincial Hospital, Fuzhou Fujian 350001; 3. College of Traditional Chinese Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou Fujian 350001; 4. Integrated Chinese and Western Medicine College, Fujian University of Traditional Chinese Medicine, Fuzhou Fujian 350001, China)
Abstract:Objective: To study the expression of miR4306 in osteosarcoma cells and its effect on the biological behavior of osteosarcoma cells. Methods: Human osteoblast hFOB 1.19 and osteosarcoma cells Saos2, MNNG/HOS CI #5 were selected, and qRTPCR was used to detect the expression level of miR4306. miR4306 mimics and negative control were transfected into osteosarcoma cells Saos2 and MNNG/HOS CI #5, respectively; and cell proliferation was detected by CCK8 assay and colony formation assay, cell migration and invasion were detected by Transwell assay, and Western blotting was used to detect the expression levels of epithelialmesenchymal transition (EMT) marker proteins. The online target gene prediction websites Targetscan and Starbase predicted that the target gene of miR4306 might be special ATrich sequencebinding protein 2 (SATB2), and the luciferase reporter system was used to identify the target relationship. miR4306 mimics and LVSATB2 were cotransfected into osteosarcoma cells, and the changes in cell proliferation, migration, invasion and EMT marker protein expression levels were detected. Results: Compared with human osteoblast hFOB 1-19, the expression of miR-4306 in osteosarcoma cells Saos-2 and MNNG/HOS CI #5 was significantly decreased (both P<0.01). After transfection with miR-4306 mimics, the proliferation, migration and invasion abilities of osteosarcoma cells were significantly decreased, the expression levels of Ncadherin and vascular endothelial growth factor were significantly decreased, and the expression level of Ecadherin was greatly increased (P<0.05 or<0.01). SATB2 is a direct downstream target of miR-4306; compared with the miR-4306 mimics+LV-NC group, the miR-4306 mimics+LV-SATB2 group partially reversed the effects of miR-4306 on osteosarcoma cell proliferation, invasion, migration and EMT. Conclusion: miR-4306 is lowly expressed in osteosarcoma cells, and it could inhibit osteosarcoma cell proliferation, migration, invasion and EMT by downregulating the expression of SATB2.
李书林, 廖艺琳, 周子杰,等.. miR-4306通过下调SATB2表达抑制骨肉瘤细胞增殖、迁移与侵袭[J]. 江苏大学学报:医学版, 2023, 33(01): 42-48.
LI Shulin1,2, LIAO Yilin3, ZHOU Zijie4, XIAO Zhengwei1, SU Lingbo1, LI Junjie1, LAN Qing1, CHEN Mingdi1, GUO Huiling1,2, YAN Laipeng1,2, TANG Faqiang1,2. miR4306 inhibits the proliferation, migration and invasion of osteosarcoma cells by down-regulating the expression of special AT-rich sequence-binding protein 2
. Journal of Jiangsu University(Medicine Edition), 2023, 33(01): 42-48.
[1]Angulo P, Kaushik G, Subramaniam D, et al. Natural compounds targetingmajor cell signaling pathways: a novel paradigm for osteosarcoma therapy[J]. J Hematol Oncol, 2017, 10(1): 1-13.
[2]Isakoff MS, Bielack SS, Meltzer P, et al. Osteosarcoma:current treatment and a collaborative pathway to success[J]. J Clin Oncol, 2015, 33(27): 3029-3035.
[3]Bhattacharya S, Chalk AM, Ng AJ, et al. Increased miR1555p and reduced miR148a3p contribute to the suppression of osteosarcoma cell death[J]. Oncogene, 2016, 35(40): 5282-5294.
[4]Luetke A, Meyers PA, Lewis I, et al. Osteosarcoma treatmenwhere do we stand? A state of the art review[J]. Cancer Treat Rev, 2014, 40(4): 523-532.
[5]Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs[J]. Genome Res, 2009, 19(1): 92-105.
[6]Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes[J]. Cell, 2012, 149(3): 515-524.
[7]Budakoti M, Panwar AS, Molpa D, et al. MicroRNA: the darkhorse of cancer[J]. Cell Signal, 2021, 83: 109995.
[8]Hata A, Lieberman J. Dysregulation of microRNA biogenesis and gene silencing in cancer[J]. Sci Signal, 2015, 8(368): re3.
[9]Hess J, Unger K, Maihoefer C, et al. A fivemicroRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV infection[J]. Clin Cancer Res, 2019, 25(5): 1505-1516.
[10]Zhao Z, Li L, Du P, et al. Transcriptional downregulation of miR4306 serves as a new therapeutic target for triple negative breast cancer [J]. Theranostics, 2019, 9(5): 1401-1416.
[11]Dai D, Tan Y, Guo L, et al. Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing[J]. Eur J Endocrinol, 2020, 182(1): 111-121.
[12]Yang Y, Luo H, Liu S, et al. Platelet microparticlescontaining miR4306 inhibits human monocytederived macrophages migration through VEGFA/ERK1/2/NFκB signaling pathways[J]. Clin Exp Hypertens, 2019, 41(5): 481-491.
[13]Lu S, Wang Y, Liu G, et al. Construction and validation of nomogram to predict distant metastasis in osteosarcoma: a retrospective study[J]. J Orthop Surg Res, 2021, 16(1): 231.
[14]Polyak K, Haviv I, Campbell IG. Coevolution of tumor cells and their microenvironment [J]. Trends Genet, 2009, 25(1): 30-38.
[15]Kong D, Zhou H, Neelakantan D, et al. VEGFC mediates tumor growth and metastasis through promoting EMTepithelial breast cancer cell crosstalk[J]. Oncogene, 2021, 40(5): 964-979.
[16]Qiu Y, Liu Y, Li WH, et al. P2Y2 receptor promotes the migration and invasion of breast cancer cells via EMTrelated genes Snail and Ecadherin[J]. Oncol Rep, 2018, 39(1): 138-150.
[17]Chen QY, Costa M. Oncogenic and tumor suppressive roles of special ATrich sequencebinding protein [J]. J Carcinog, 2018, 17: 2.
[19]Kucuksayan H, Ozes ON, Akca H. Downregulation of SATB2 is critical for induction of epithelialtomesenchymal transition and invasion of NSCLC cells[J]. Lung Cancer, 2016, 98: 122-129.